Skip to main content

RT @doctorRBC: C-VIEW Study: Certolizumab reduced Anterior Uveitis flares in AxSpA ⭐️82% ⬇️ in uveitis flare ev

Social Author Name
Robert B Chao, MD
Tweet Content
C-VIEW Study: Certolizumab reduced Anterior Uveitis flares in AxSpA ⭐️82% ⬇️ in uveitis flare event ⭐️reduction in axSpA disease activity ⭐️no new safety signals POS0897 #EULAR2021 @RheumNow https://t.co/182iHfkSTY
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×